Osaic Holdings
ACRS icon

Osaic Holdings’s Aclaris Therapeutics ACRS Stock Holding History

Osaic Holdings’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89K Buy
+735
New +$3.28K ﹤0.01% 7048
2026
Q1 		– Sell
-730
Closed -$2.2K – 7801
2025
Q4 		$2.2K Hold
730
– – ﹤0.01% 7064
2025
Q3 		$1.4K Hold
730
– – ﹤0.01% 7247
2025
Q2 		$1.04K Sell
730
-740
-50% -$1K ﹤0.01% 7137
2025
Q1 		$2.25K Sell
1,470
-1,212
-45% -$2.58K ﹤0.01% 6544
2024
Q4 		$6.65K Buy
2,682
+950
+55% +$2.36K ﹤0.01% 6034
2024
Q3 		$1.99K Buy
+1,732
New +$2.12K ﹤0.01% 6615
2024
Q2 		– Sell
-124
Closed -$154 – 7390
2024
Q1 		$154 Buy
+124
New +$148 ﹤0.01% 6995
2023
Q4 		– Sell
-33
Closed -$226 – 7284
2023
Q3 		$226 Buy
33
+17
+106% +$145 ﹤0.01% 7131
2023
Q2 		$166 Hold
16
– – ﹤0.01% 7235
2023
Q1 		$129 Buy
+16
New +$203 ﹤0.01% 7309
2021
Q3 		– Sell
-3,195
Closed -$56K – 7155
2021
Q2 		$56K Buy
3,195
+300
+10% +$6.82K ﹤0.01% 4954
2021
Q1 		$73K Sell
2,895
-1,105
-28% -$21.6K ﹤0.01% 4588
2020
Q4 		$26K Hold
4,000
– – ﹤0.01% 4990
2020
Q3 		$10K Sell
4,000
-1,000
-20% -$2.24K ﹤0.01% 5248
2020
Q2 		$8K Hold
5,000
– – ﹤0.01% 5265
2020
Q1 		$5K Buy
+5,000
New +$6.81K ﹤0.01% 5309

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Osaic Holdings's ACRS Position: Q2 2026 in Review

Osaic Holdings opened a new position in Aclaris Therapeutics (ACRS) in Q2 2026: 735 shares worth $3.89K. The stake represents ﹤0.01% of the portfolio and ranks #7048 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in ACRS as recently as Q4 2025.

Osaic Holdings first reported a position in ACRS in Q1 2020 and has held it in 17 quarters since. The position peaked at $73K in Q1 2021. 148 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • Osaic Holdings held 735 shares of Aclaris Therapeutics worth $3.89K as of Q2 2026.
  • Aclaris Therapeutics was a new Osaic Holdings position in Q2 2026.
  • Aclaris Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7048 holding.
  • Osaic Holdings first reported a position in Aclaris Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • Osaic Holdings's Aclaris Therapeutics position peaked at $73K in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.